Skip to main content
OpenTrials
Completed

NCT Number: NCT05378776

Sucrose at Triage for Acute Gastroenteritis Episode in Children

Background: Acute viral gastroenteritis is a very common pediatric medical condition that results in a large number of emergency department (ED) visits. Fasting-induced ketosis has been suggested to contribute to nausea and vomiting in children with VGE. To date, there is no data on the impact of oral sucrose intake during oral rehydration.

Objective: The aim of this study is to assess the impact of providing a sucrose solution at triage to young children with suspected acute viral gastroenteritis on the amount of rehydration solution intake in the first 2 hours. We will also assess the proportion of discharge after initial medical evaluation, the proportion of oral rehydration failure, the number of vomiting episodes per patient, ondansetron administration, the time between the intervention and ED discharge, the time between the first medical contact and ED discharge and return visits within 48 hours.

Methods:

This study will be a double-blind randomized controlled trial. Recruitment will take place in a tertiary pediatric ED. Participants will be all children who present to the ED with suspected acute acute viral gastroenteritis with at least three vomiting in the previous 24 hours. The intervention will consist in giving 1.5 ml/kg of a sucrose solution composed of diluted juice with added table sugar (3.5g of sucrose/10 ml) compared with 1.5 ml/kg of diluted juice (0.5g of sucrose/10 mL, standard of care in our ED). Following that, all participants will be rehydrated with 15 mL of diluted juice every 15 minutes or more if tolerated. The primary outcome will be the amount of rehydration solution (ml) absorbed in the first two hours following intervention. Secondary outcomes will include disposition after initial medical evaluation, oral rehydration failure, the number of vomiting, ondansetron administration, the time between the intervention and ED discharge, the time between the first medical contact and ED discharge and return visits within 48 hours. The primary analysis will be the difference in the amount of tolerated oral rehydration between the two groups. Based on a preliminary study of children suffering from VGE, it was estimated that the recruitment of 238 participants would provide a power of 80% to identify a difference of 15 ml between the two groups.

Expected results:

We hope that this study will demonstrate that an oral sucrose solution given at triage to children presenting with symptoms compatible with acute acute viral gastroenteritis promotes oral hydration and consequently increases the total amount of rehydration solution tolerated by children.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–83 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sainte-Justine Hospital

Montreal, Quebec, H3T1C5, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged 6 months to 6 years. We will restrict to this age group to have a more homogenous group.
  • At least 3 non-bilious, non-bloody, vomiting in the last 24 hours
  • No other diagnostic more likely than acute viral gastroenteritis suspected at triage

Exclusion criteria

  • Severe dehydration (based on poor capillary refill or hypotension)
  • Hypoglycemia identified by the triage nurse (< 2,8 mmol)
  • Bilious or bloody vomiting
  • Chronic disease other than asthma
  • Previous inclusion in the study
  • Inability to obtain parental informed consent (language barrier, absence, etc.)

Treatment and study plan

Sucrose

Dietary Supplement

The experimental arm will receive 1.5 ml/kg of the sucrose solution at triage (once). The composition of the homemade sucrose solution used in our emergency department is 3.5 g of table sugar (sucrose) mixed with 10 ml of water. For this double-blind study, we replaced water with diluted juice (see standard arm description) to obtain a solution with the same appearance as the standard arm. With the idea of correcting ketosis, we chose to provide the same amount of sugar as we do in hypoglycemia (0.4-0.5 g/kg of dextrose) to participants in the intervention group, which represents 1.5 ml/kg of the sucrose solution containing 0.4 g of sucrose/mL for a total of 0.6 g/kg of sucrose.

Standard rehydration solution

Dietary Supplement

This group will receive 1.5 mL/kg of diluted juice composed of juice (apple or orange) and water in equal proportion once at triage. This solution contains 0.05 g/ml of sucrose for a total of 0.075 g/kg of sucrose (eight times less than the intervention arm).

Primary outcomes

  1. Mean amount of tolerated oral rehydration in mL

    Time frame: 2 hours after intervention

    The total amount of rehydration solution tolerated during the two hours following intervention. This will be the amount of solution absorbed by the child without vomiting. In case of vomiting, the amount of solution absorbed will be the amount of solution tolerated after vomiting. In the few situations when the children will be discharged from the ED before two hours, we will collect the amount of solution tolerated before discharge.

Secondary outcomes

  1. Number of participants who needed an observation

    Time frame: 2 hours

    Patient who are not immediately discharged by the treating physician after the first evaluation

  2. Number of participants with oral rehydration failure

    Time frame: 6 hours

    Patient who need an intravenous rehydration during ED stay

  3. Mean number of vomiting

    Time frame: 6 hours

    Number of vomiting episode per patient during ED stay

  4. Number of participants who received ondansetron

    Time frame: 6 hours

    Number of patients who received ondansetron during ED stay

  5. Mean length of stay

    Time frame: 24 hours

    The time between the intervention and ED discharge

  6. Mean length of stay after physician evaluation

    Time frame: 24 hours

    The time between the first evaluation by a physician and ED discharge

  7. Number of participants who had a return visit

    Time frame: 48 hours

    return visit to the ED

Sponsors and collaborators

Lead sponsor

Jocelyn Gravel

Other

Registry information

Official study title

Triage Administration of Sucrose for Gastroenteritis in Children; a Randomized Controlled Trial

Acronym: STAGE

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
May 18, 2022
Registry last updated
May 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.